Testing version — LOERadar is in active testing. Features and data may change.
REMERON (MIRTAZAPINE) | LOERadar
REMERON
NDA
MIRTAZAPINE | N020415 | ORGANON USA LLC
3 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (3)
Sort:
#001 — 15MG
RLDAB
0 patents0 exclusivities▴
TABLET;ORAL | Approved: Jun 14, 1996
No patent or exclusivity listings for this strength.
#002 — 30MG
RLDAB
0 patents0 exclusivities▾
TABLET;ORAL | Approved: Jun 14, 1996
#003 — 45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**